104 related articles for article (PubMed ID: 9000141)
1. Genomic structure and developmental expression of the mouse cell cycle regulatory transcription factor DP1.
Gopalkrishnan RV; Dollé P; Mattei MG; La Thangue NB; Kedinger C
Oncogene; 1996 Dec; 13(12):2671-80. PubMed ID: 9000141
[TBL] [Abstract][Full Text] [Related]
2. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F.
Ormondroyd E; de la Luna S; La Thangue NB
Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
Hiyama H; Iavarone A; Reeves SA
Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
[TBL] [Abstract][Full Text] [Related]
4. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
Darbinian N; Gallia GL; Kundu M; Shcherbik N; Tretiakova A; Giordano A; Khalili K
Oncogene; 1999 Nov; 18(46):6398-402. PubMed ID: 10597240
[TBL] [Abstract][Full Text] [Related]
5. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.
Ohtani K; Iwanaga R; Nakamura M; Ikeda M; Yabuta N; Tsuruga H; Nojima H
Oncogene; 1999 Apr; 18(14):2299-309. PubMed ID: 10327050
[TBL] [Abstract][Full Text] [Related]
6. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional control elements of the rat thymidylate synthase promoter: evolutionary conservation of regulatory features.
Lee Y; Johnson LF
Exp Cell Res; 2000 Jul; 258(1):53-64. PubMed ID: 10912787
[TBL] [Abstract][Full Text] [Related]
9. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
10. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
Oncogene; 1999 Sep; 18(36):5015-23. PubMed ID: 10490838
[TBL] [Abstract][Full Text] [Related]
12. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
Rotheneder H; Geymayer S; Haidweger E
J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
[TBL] [Abstract][Full Text] [Related]
13. Evidence for GEAPS, novel Glial E2F1-Associated Proteins in hamster glioma cells induced by the human neurotropic polyomavirus, JCV.
Raj GV; Ansari SA; Khalili K
Oncogene; 1996 Mar; 12(6):1279-88. PubMed ID: 8649830
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
[TBL] [Abstract][Full Text] [Related]
15. Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1.
Alevizopoulos K; Sanchez B; Amati B
Oncogene; 2000 Apr; 19(16):2067-74. PubMed ID: 10803468
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
[TBL] [Abstract][Full Text] [Related]
17. Transcription from TATA-less promoters: dihydrofolate reductase as a model.
Azizkhan JC; Jensen DE; Pierce AJ; Wade M
Crit Rev Eukaryot Gene Expr; 1993; 3(4):229-54. PubMed ID: 8286846
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
19. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
20. Regulation of E2F-1 gene expression in avian cells.
Espanel X; Le Cam L; North S; Sardet C; Brun G; Gillet G
Oncogene; 1998 Aug; 17(5):585-94. PubMed ID: 9704924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
